ArticleTrials2019

Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.

Jingjing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.